C.M. Bidwell & Associates’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-201	Closed	-$119K	–	530
2022 Q2	$119K	Hold	201	–	–	0.09%	195
2022 Q1	$140K	Sell	201 -252	-56%	-$159K	0.09%	201
2021 Q4	$286K	Buy	453 +252	+125%	+$155K	0.18%	102
2021 Q3	$122K	Buy	+201	New	+$125K	0.08%	229
2021 Q1	–	Sell	-156	Closed	-$75K	–	544
2020 Q4	$75K	Sell	156 -359	-70%	-$194K	0.06%	256
2020 Q3	$288K	Sell	515 -155	-23%	-$94K	0.27%	66
2020 Q2	$418K	Buy	670 +461	+221%	+$262K	0.38%	46
2020 Q1	$102K	Buy	+209	New	+$86.2K	0.11%	168
2019 Q2	–	Sell	-520	Closed	-$214K	–	445
2019 Q1	$214K	Sell	520 -15	-3%	-$6.18K	0.21%	123
2018 Q4	$200K	Buy	+535	New	+$196K	0.22%	126
2018 Q2	–	Sell	-1,050	Closed	-$362K	–	444
2018 Q1	$362K	Buy	1,050 +50	+5%	+$17.4K	0.33%	83
2017 Q4	$376K	Buy	+1,000	New	+$405K	0.32%	92
2016 Q4	–	Sell	-10,020	Closed	-$4.03M	–	295
2016 Q3	$4.03M	Hold	10,020	–	–	0.96%	39
2016 Q2	$3.5M	Hold	10,020	–	–	0.87%	70
2016 Q1	$3.61M	Buy	+10,020	New	+$4.13M	0.9%	62